BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36127128)

  • 1. Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation.
    Herasevich S; Frank RD; Hogan WJ; Alkhateeb H; Limper AH; Gajic O; Yadav H
    Respir Care; 2023 Jan; 68(1):77-86. PubMed ID: 36127128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell Transplantation.
    Herasevich S; Frank RD; Bo H; Alkhateeb H; Hogan WJ; Gajic O; Yadav H
    Ann Am Thorac Soc; 2021 Jun; 18(6):1004-1012. PubMed ID: 33321053
    [No Abstract]   [Full Text] [Related]  

  • 3. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
    Barlas T; İnci K; Aygencel G; Türkoğlu M; Tunçcan ÖG; Can F; Aydın Kaynar L; Özkurt ZN; Yeğin ZA; Yağcı M
    Hematology; 2021 Dec; 26(1):328-339. PubMed ID: 33818297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
    Youssef S; Rodriguez G; Rolston KV; Champlin RE; Raad II; Safdar A
    Medicine (Baltimore); 2007 Mar; 86(2):69-77. PubMed ID: 17435587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole blood RNA sequencing reveals a unique transcriptomic profile in patients with ARDS following hematopoietic stem cell transplantation.
    Englert JA; Cho MH; Lamb AE; Shumyatcher M; Barragan-Bradford D; Basil MC; Higuera A; Isabelle C; Vera MP; Dieffenbach PB; Fredenburgh LE; Kang JB; Bhatt AS; Antin JH; Ho VT; Soiffer RJ; Howrylak JA; Himes BE; Baron RM
    Respir Res; 2019 Jan; 20(1):15. PubMed ID: 30665420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe sepsis in hematopoietic stem cell transplant recipients*.
    Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
    Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure after allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Zhao T; Yan CH; Sun YQ; Liu KY; Huang XJ
    Int J Cardiol; 2013 Sep; 167(6):2502-6. PubMed ID: 22727962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications Associated with Peripherally Inserted Central Catheters (PICC) in People Undergoing Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Home Hospitalization.
    Garcés-Carrasco AM; Santacatalina-Roig E; Carretero-Márquez C; Martínez-Sabater A; Balaguer-López E
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
    Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
    Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
    Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
    Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early high dose corticosteroid therapy in hematopoietic stem cell transplantation patients with acute respiratory distress syndrome: a propensity score matched study.
    Hu Y; Shen J; An Y; Liu S
    Ther Adv Respir Dis; 2021; 15():17534666211009397. PubMed ID: 33888016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection.
    Ammad Ud Din M; Jaan A; Shahzad M; Liaqat H; McGuirk J; Mushtaq MU
    Transpl Infect Dis; 2023 Jun; 25(3):e14066. PubMed ID: 37129229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant thrombocytopenia predicts engraftment time and blood products requirement in allogeneic hematopoietic stem cell transplantation patients.
    Roshandel E; Kaviani S; Hajifathali A; Soleimani M
    Transfus Apher Sci; 2020 Aug; 59(4):102810. PubMed ID: 32430259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
    Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.